Finance

Lists
IRON:NASDAQ
Disc Medicine Inc
$77.12
-1.11%
(-0.87) 1D
Nov 19, 12:32:36 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IRON...
Open
$78.44
High
$79.02
Low
$76.22
Mkt. cap
3.51B
Avg. vol.
1.37M
Volume
96.65K
52-wk high
$99.50
52-wk low
$40.00
EPS
-$6.33
Beta
0.96
Shares outstanding
45.54M
No. of employees
173
Open
$78.44
High
$79.02
Low
$76.22
Mkt. cap
3.51B
Avg. vol.
1.37M
Volume
96.65K
52-wk high
$99.50
52-wk low
$40.00
EPS
-$6.33
Beta
0.96
Shares outstanding
45.54M
No. of employees
173
News stories
From web sources and news partners
About Disc Medicine Inc
CEO-
Employees173
Founded2015
HeadquartersWatertown, Massachusetts, United States
SectorHealth Care
IndustryBiotechnology
Analyst ratings
Based on 10 analysts giving stock ratings to IRON in the past 3 months
Strong buy
Buy
10
Hold
0
Sell
0
12-month forecast
Based on 10 Wall Street analysts offering 12 month price targets for IRON in the last 3 months.
Highest
Current $77.12
$170.00 (+120.45%)
Average
$126.20 (+63.65%)
Lowest
$104.00 (+34.86%)
Analyst
Recommendation
Action
Price target
Projected
Date
Kristen Kluska
Cantor Fitzgerald
Buy
Maintained
$170.00
+120.4%
11/18/2026
Sean Laaman
Morgan Stanley
Buy
Reiterated
$104.00
+34.9%
11/18/2026
Evan Seigerman
BMO Capital
Buy
Maintained
$120.00
+55.6%
11/09/2026
Debjit Chattopadhyay
Guggenheim
Buy
Initiated
$132.00
+71.2%
11/08/2026
Danielle Brill
Truist Financial
Buy
Maintained
$115.00
+49.1%
11/06/2026
Douglas Tsao
H.C. Wainwright
Buy
Reiterated
$127.00
+64.7%
11/06/2026
David Nierengarten
Wedbush
Buy
Maintained
$110.00
+42.6%
11/06/2026
Thomas Smith
Leerink Partners
Buy
Reiterated
$130.00
+68.6%
10/27/2026
Rami Katkhuda
LifeSci Capital
Buy
Maintained
$130.00
+68.6%
10/19/2026
Derek Archila
Wells Fargo
Buy
Reiterated
$124.00
+60.8%
10/20/2026
Stephen Willey
Stifel Nicolaus
Buy
Maintained
$111.00
+43.9%
07/31/2026
Tara Bancroft
TD Cowen
Buy
Maintained
-
-
07/30/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
45.37M
45.90M
46.93M
44.08M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
20.75M
23.62M
18.14M
20.08M
Operating expense
66.12M
69.52M
65.08M
64.16M
Total operating expenses
66.12M
69.52M
65.08M
64.16M
Operating income
-66.12M
-69.52M
-65.08M
-64.16M
Other non operating income
-2.00K
22.00K
-12.00K
-5.00K
EBT including unusual items
-60.44M
-63.45M
-59.46M
-59.43M
EBT excluding unusual items
-59.59M
-63.45M
-59.46M
-59.43M
Income tax expense
88.00K
51.00K
69.00K
109.00K
Effective tax rate
-0.15%
-0.08%
-0.12%
-0.18%
Other operating expenses
-
-
-
-
Net income
-60.53M
-63.50M
-59.53M
-59.54M
Net profit margin
-
-
-
-
Earnings per share
-1.62
-1.65
-1.54
-1.53
Interest and investment income
7.41M
6.89M
6.53M
6.45M
Interest expense
-883.00K
-844.00K
-908.00K
-1.71M
Net interest expenses
6.53M
6.05M
5.62M
4.74M
Depreciation and amortization charges
-
-
-
-
EBITDA
-66.03M
-69.44M
-64.98M
-64.07M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps